[1]
Davidson, L. et al. 2022. Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factor-alpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance Center. Acta Dermato-Venereologica. 102, (Feb. 2022), adv00648. DOI:https://doi.org/10.2340/actadv.v102.175.